Developing bespoke gene editing treatments for patients with carbamoyl phosphate synthetase 1 (CPS1) deficiency in real time: successes and challenges

Xiao Wang is a Research Assistant Professor of Cardiovascular Institute in the Perelman School of Medicine at the University of Pennsylvania. She received her B.S. in Biochemistry from Zhejiang University and Ph.D. degree in Molecular & Cell Biology from Chinese Academy of Sciences. After that, she was a Postdoctoral Fellow at Harvard University and the University of Pennsylvania. She has co-authored over 30 research papers. Her research focuses on the genetics of cardiovascular disease, seeks to identify genetic factors that cause or protect against disease, and uses novel genome-editing tools to develop new therapies. Most recently she extends her research interest to using novel genome-editing technologies to develop new ways to cure diseases caused by inherited mutations in the genome.